Posts Tagged ‘CDRH’
A conversation at the frontier of digital health innovation, FDA regulations, and cognitive health
Digital Therapeutics for MCI and Alzheimer’s disease: A Regulatory Perspective (The Journal of Prevention of Alzheimer’s Disease): –This article is adapted from a comprehensive conversation between Dr. Murali Doraiswamy and Dr. Jeffrey Shuren at the 2021 Clinical Trials on Alzheimer’s Disease (CTAD) conference in Boston. Dr. Shuren is a behavioral neurologist who has held a variety…
Read More